Besides, whether DAPK1 is dysregulated in other AD mouse models of Aβ (e.g., APP/PS1 or 5×FAD) or tau (e.g., PS19 or tau P301L) pathologies remains to be characterized. This evidence concerns the gene MAPT and Alzheimer disease.